Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Glioma × Injections × Clear all

Phase

Status

Recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Leukemia, Myeloid, Acute 11 Recurrence 3 Myelodysplastic Syndromes 3 Leukemia, Myelomonocytic, Chronic 3 Neoplasm Metastasis 2 Lymphoma, B-Cell 2 Leukemia, Monocytic, Acute 2 Breast Neoplasms 2 Advanced Solid Tumors 2 Solid Tumor 1 Small Cell Lung Carcinoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Papillomavirus Infections 1 Ovarian Neoplasms 1 Non-Squamous Non-small Cell Lung Cancer 1 Nasopharyngeal Carcinoma 1 Myeloproliferative Disorders 1 Myelodysplastic-Myeloproliferative Diseases 1 Microsatellite Instability 1 Melanoma 1 Lymphoma, Large B-Cell, Diffuse 1 Leukemia, Myelomonocytic, Acute 1 Leukemia, Myeloid, Accelerated Phase 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Leukemia, Basophilic, Acute 1 Leukemia 1 Glioma 1 Glioblastoma 1 Fallopian Tube Neoplasms 1 EGFR Positive Non-small Cell Lung Cancer 1

Interventions

Magnetic Resonance Spectroscopy 13 Temozolomide 9 Specimen Handling 8 X-Rays 6 Radiotherapy 6 Biopsy 6 Phantoms, Imaging 5 Nuclear Medicine Department, Hospital 5 trametinib 4 olaparib 3 dabrafenib 3 Radiotherapy, Intensity-Modulated 3 Nivolumab 3 ulixertinib 2 tipifarnib 2 selpercatinib 2 pembrolizumab 2 niraparib 2 larotrectinib 2 ivosidenib 2 erdafitinib 2 ensartinib 2 atezolizumab 2 Surveys and Questionnaires 2 Radiation 2 Proton Therapy 2 Lomustine 2 Irinotecan 2 Gemcitabine 2 CLR1404 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04808245 2025-09-22

INTERCEPT-H3

German Cancer Research Center

Phase 1 Active not recruiting

Glioblastoma, Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡